TCM Biotech International Corp. (TPEX:4169)
Taiwan · Delayed Price · Currency is TWD 170.00
-8.50 (-4.76%)
Mar 24, 2026, 1:59 PM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 10.54 billion as of March 23, 2026. Its market cap has increased by 207.76% in one year.
Market Cap
10.54B
Enterprise Value
10.03B
Revenue
685.49M
Ranking
n/a
PE Ratio
549.83
Stock Price
170.00
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 10.54B, an increase of 670.48%. That is a compound annual growth rate of 15.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 10.54B | 3.18% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 17.11B |
| EirGenix | 17.10B |
| Medigen Vaccine Biologics | 16.31B |
| AP Biosciences | 15.79B |
| TaiMed Biologics | 13.26B |
| Ever Supreme Bio Technology | 12.39B |
| Tanvex BioPharma | 11.28B |
| Gongwin Biopharm Holdings | 8.80B |